About FDA

Report on FY 2008 OCP Activities and Impacts

FY 2008 OCP Performance Report

This section reports the activities and impacts of OCP in the assignment of combination products and in coordinating the review and regulation of combination products for
FY 2008. Consistent with the mandated functions of OCP, data highlighted in this section include:

  • Prompt assignment of combination products
  • Timely and effective premarket review
  • Consistent and appropriate postmarket regulation
  • Effective resolution of review disputes

Unless otherwise noted, all performance data in this section are as of September 30, 2008.

Next page: Overview of Activities and Impacts

Page Last Updated: 09/10/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English